AstraZeneca manufacturing error clouds vaccine study results
Published
In a surprise, the group of volunteers that got a lower dose seemed to be much better protected than the volunteers who got two full doses.
Full ArticlePublished
In a surprise, the group of volunteers that got a lower dose seemed to be much better protected than the volunteers who got two full doses.
Full ArticleAstraZeneca PLC (LON:AZN) said it is mulling undertaking a new trial for the coronavirus (COVID-19) vaccine developed with Oxford..
“You’ve taken two studies for which different doses were used and come up with a composite that doesn’t represent either of..